Using Channel Data Analytics for 340B Monitoring and Audit Support

Check out our webinar covering how pharmaceutical manufacturers can utilize channel data analytics to drive monitoring and auditing of their 340B programs. 

The webinar covers the changing breadth of the 340B Discount Drug Program and the insights offered in the Health Resources and Services Administration’s (HRSA’s) recently released mega-guidance, including results of its program-integrity audits.  David Weiss, IntegriChain Director of Solution Engineering and subject matter expert, will lead the webinar, and guest speaker Michael Townsend, IDC Health Insights Research Manager, Life Sciences Business Systems Strategies, will offer industry insights.